Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP577663.RAK0VxvjMUVcTccr4F05itamV6JgZby2Z4op_wy1G2NTE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP577663.RAK0VxvjMUVcTccr4F05itamV6JgZby2Z4op_wy1G2NTE130_assertion type Assertion NP577663.RAK0VxvjMUVcTccr4F05itamV6JgZby2Z4op_wy1G2NTE130_head.
- NP577663.RAK0VxvjMUVcTccr4F05itamV6JgZby2Z4op_wy1G2NTE130_assertion description "[No notable effect was found for polymorphisms in MTR or MTRR either, although MTR Ex26-20 A>G and MTRR Ex5+123C>T polymorphisms were associated with a borderline increased risk of stomach cancer (MTR Ex26-20A>G, AG/GG versus AA: odds ratio, 1.35; 95% confidence interval, 0.96-1.90; MTRR Ex5+123C>T, CT/TT versus CC: odds ratio, 1.30; 95% confidence interval, 0.93-1.82).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577663.RAK0VxvjMUVcTccr4F05itamV6JgZby2Z4op_wy1G2NTE130_provenance.
- NP577663.RAK0VxvjMUVcTccr4F05itamV6JgZby2Z4op_wy1G2NTE130_assertion evidence source_evidence_literature NP577663.RAK0VxvjMUVcTccr4F05itamV6JgZby2Z4op_wy1G2NTE130_provenance.
- NP577663.RAK0VxvjMUVcTccr4F05itamV6JgZby2Z4op_wy1G2NTE130_assertion SIO_000772 17220339 NP577663.RAK0VxvjMUVcTccr4F05itamV6JgZby2Z4op_wy1G2NTE130_provenance.
- NP577663.RAK0VxvjMUVcTccr4F05itamV6JgZby2Z4op_wy1G2NTE130_assertion wasDerivedFrom befree-20150227 NP577663.RAK0VxvjMUVcTccr4F05itamV6JgZby2Z4op_wy1G2NTE130_provenance.
- NP577663.RAK0VxvjMUVcTccr4F05itamV6JgZby2Z4op_wy1G2NTE130_assertion wasGeneratedBy ECO_0000203 NP577663.RAK0VxvjMUVcTccr4F05itamV6JgZby2Z4op_wy1G2NTE130_provenance.